Correlation Between Xtrackers ShortDAX and CITIUS PHARMAC

Can any of the company-specific risk be diversified away by investing in both Xtrackers ShortDAX and CITIUS PHARMAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xtrackers ShortDAX and CITIUS PHARMAC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Xtrackers ShortDAX and CITIUS PHARMAC DL, you can compare the effects of market volatilities on Xtrackers ShortDAX and CITIUS PHARMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xtrackers ShortDAX with a short position of CITIUS PHARMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xtrackers ShortDAX and CITIUS PHARMAC.

Diversification Opportunities for Xtrackers ShortDAX and CITIUS PHARMAC

0.69

Correlation Coefficient

Xtrackers ShortDAX  CITIUS PHARMAC

Poor diversification

The 3 months correlation between Xtrackers and CITIUS is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Xtrackers ShortDAX and CITIUS PHARMAC DL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CITIUS PHARMAC DL and Xtrackers ShortDAX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xtrackers ShortDAX are associated (or correlated) with CITIUS PHARMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CITIUS PHARMAC DL has no effect on the direction of Xtrackers ShortDAX i.e., Xtrackers ShortDAX and CITIUS PHARMAC go up and down completely randomly.

Pair Corralation between Xtrackers ShortDAX and CITIUS PHARMAC

Assuming the 90 days trading horizon Xtrackers ShortDAX is expected to under-perform the CITIUS PHARMAC. But the etf apears to be less risky and, when comparing its historical volatility, Xtrackers ShortDAX is 1.71 times less risky than CITIUS PHARMAC. The etf trades about -0.32 of its potential returns per unit of risk. The CITIUS PHARMAC DL is currently generating about -0.18 of returns per unit of risk over similar time horizon. If you would invest  387.00  in CITIUS PHARMAC DL on October 22, 2024 and sell it today you would lose (58.00) from holding CITIUS PHARMAC DL or give up 14.99% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	97.37%
Values	Daily Returns

Xtrackers ShortDAX  vs.  CITIUS PHARMAC DL

Xtrackers ShortDAX

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Xtrackers ShortDAX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Etf's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the Exchange Traded Fund stockholders.

CITIUS PHARMAC DL

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CITIUS PHARMAC DL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Xtrackers ShortDAX and CITIUS PHARMAC

The main advantage of trading using opposite Xtrackers ShortDAX and CITIUS PHARMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xtrackers ShortDAX position performs unexpectedly, CITIUS PHARMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CITIUS PHARMAC will offset losses from the drop in CITIUS PHARMAC's long position.

The idea behind Xtrackers ShortDAX and CITIUS PHARMAC DL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.